Trilaciclib is the first FDA-approved therapy in its class to help protect bone marrow cells from damage caused by chemotherapy.
Florida Cancer Specialists & Research Institute
Advertisement
Articles by Florida Cancer Specialists & Research Institute
Physicians can make an exact diagnosis and prognosis and plan treatment that targets a specific tumor with great precision.
Are smoothies as good as actually eating those fruits and vegetables?
Swift treatment can improve cancer survival rates.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADCs in Breast Cancer: Shaping the Future of HER2– and TROP2-Targeted Therapy
2
FDA Approves Gepotidacin for Urogenital Gonorrhea in Adult and Pediatric Patients
3
Study: Many Patients Switching Biologics Because of Perceived Lack of Efficacy Treating Asthma
4
Emerging Data from the DESTINY-Breast Trials Signal Shift in Standards of Care for HER2-Positive Breast Cancer
5
